Product
Imprime PGG
3 clinical trials
3 indications
Indication
Breast CancerIndication
Colorectal CancerIndication
Indolent B Cell Non-Hodgkin LymphomaClinical trial
A Multicenter, Open-label, Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With Metastatic Breast Cancer (mBCA) Who Have Progressed Through Prior Hormonal TherapyStatus: Completed, Estimated PCD: 2023-03-22
Clinical trial
A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC)Status: Terminated, Estimated PCD: 2022-09-26
Clinical trial
A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin LymphomaStatus: Completed, Estimated PCD: 2019-07-11